Not a Member?
Email this page
Send the page ""
to a friend, relative, colleague or yourself.
Separate multiple email address with a comma
We do not record any personal information entered above.
Thank you. Your email has been sent.
Soliris (eculizumab) Injection REMS
Goals of the Soliris (eculizumab) Injection REMS Program
The goals of the REMS are:• To mitigate the occurrence and morbidity associated with meningococcal infections• To educate Healthcare Professionals (HCPs) and Patients regarding: - the increased risk of meningococcal infections with Soliris - the early signs of invasive meningococcal infections, and - the need for immediate medical evaluation of signs and symptoms consistent with possible meningococcal infections
• Medication Guide• Elements to Assure Safe Use